Drug Information

Drug General Information
Drug ID
D0Q5XM
Former ID
DNC008119
Drug Name
GSK-188909
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530119]
Structure
Download
2D MOL

3D MOL
Formula
C31H36F4N4O4S
Canonical SMILES
CCNC1=CC(=C(C(=C1)C(=O)NC(CC2=CC=CC=C2)C(CNCC3=CC(=CC=C<br />3)C(F)(F)F)O)F)N4CCCCS4(=O)=O
InChI
1S/C31H36F4N4O4S/c1-2-37-24-17-25(29(32)27(18-24)39-13-6-7-14-44(39,42)43)30(41)38-26(16-21-9-4-3-5-10-21)28(40)20-36-19-22-11-8-12-23(15-22)31(33,34)35/h3-5,8-12,15,17-18,26,28,36-37,40H,2,6-7,13-14,16,19-20H2,1H3,(H,38,41)/t26-,28+/m0/s1
InChIKey
DGEILIRHSDUTDK-XTEPFMGCSA-N
PubChem Compound ID
15981486
Target and Pathway
Target(s) Beta-secretase Target Info Inhibitor [530119]
References
Ref 530119Bioorg Med Chem Lett. 2009 Jul 1;19(13):3664-8. Epub 2009 Apr 17.Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics.
Ref 530119Bioorg Med Chem Lett. 2009 Jul 1;19(13):3664-8. Epub 2009 Apr 17.Second generation of BACE-1 inhibitors. Part 1: The need for improved pharmacokinetics.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.